The relation between peripheral and central glutamate and glutamine in healthy male volunteers

Journal of Psychiatry and Neuroscience

Volumn 31, Issue 6, 2006, Pages 406-410

  Shulman, Yanina ^a,b   Grant, Suzanne ^b   Seres, Peter ^a   Hanstock, Chris ^a   Baker, Glen ^a,b   Tibbo, Philip ^a,b  

^a UNIVERSITY OF ALBERTA   (Canada)

^b UNIVERSITY OF ALBERTA   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

GLUTAMIC ACID; GLUTAMINE;

ADOLESCENT; ADULT; ARTICLE; BLOOD LEVEL; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; HUMAN; HUMAN EXPERIMENT; MALE; NORMAL HUMAN; NUCLEAR MAGNETIC RESONANCE SPECTROSCOPY; UNIVERSITY HOSPITAL;

ADOLESCENT; ADULT; CHROMATOGRAPHY, HIGH PRESSURE LIQUID; GLUTAMATES; GLUTAMINE; HUMANS; MAGNETIC RESONANCE SPECTROSCOPY; MALE; REFERENCE VALUES;

EID: 33751331468     PISSN: 11804882     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (26)

1. Krystal JH, Karper LP, Seibyl JP, et al. Subanesthetic effects of the noncompetitive NMDA antagonist, ketamine, in humans. Psychotomimetic, perceptual, cognitive, and neuroendocrine responses. Arch Gen Psychiatry 1994;51:199-214.
2. Stanley JA, Williamson PC, Drost DJ, et al. An in vivo proton magnetic resonance spectroscopy study of schizophrenia patients. Schizophr Bull 1996;22:597-609.
3. Williamson PC, Theberge J, Malla AK, et al. 4.0 Tesla 1H MRS correlates of neuronal degeneration in the left anterior cingulate and thalamus in first episode and chronic schizophrenic patients. Schizophr Res 2003;60:247.
4. Theberge J, Bartha R, Drost DJ, et al. Glutamate and glutamine measured with 4.0 T proton MRS in never-treated patients with schizophrenia and healthy volunteers. Am J Psychiatry 2002;159:1944-6.
5. Bartha R, Williamson PC, Drost DJ, et al. Measurement of glutamate and glutamine in the medial prefrontal cortex of never-treated schizophrenic patients and healthy controls by proton magnetic resonance spectroscopy. Arch Gen Psychiatry 1997;54:959-65.
6. Williamson PC, Bartha R, Drost DJ. Glutamate and glutamine on 1H MRS in never treated schizophrenic patients. Schizophr Res 1999;36:249.
7. Ohrmann P, Siegmund A, Suslow T, et al. Evidence for glutamatergic neuronal dysfunction in the prefrontal cortex in chronic but not in first-episode patients with schizophrenia: a proton magnetic resonance spectroscopy study. Schizophr Res 2005;73:153-7.
8. Kegeles LS, Shungu DC, Anjilvel S, et al. Hippocampal pathology in schizophrenia: magnetic resonance imaging and spectroscopy studies. Psychiatry Res 2000;98:163-75.
9. Bartha R, al-Semaan YM, Williamson PC, et al. A short echo proton magnetic resonance spectroscopy study of the left mesial-temporal lobe in first-onset schizophrenic patients. Biol Psychiatry 1999;45:1403-11.
10. Stanley JA, Williamson PC, Drost DJ, et al. An in vivo study of the prefrontal cortex of schizophrenic patients at different stages of illness via phosphorus magnetic resonance spectroscopy. Arch Gen Psychiatry 1995;52:399-406.
11. Block W, Bayer TA, Tepest R, et al. Decreased frontal lobe ratio of N-acetyl aspartate to choline in familial schizophrenia: a proton magnetic resonance spectroscopy study. Neurosci Lett 2000;289:147-51.
12. Rowland LM, Bustillo JR, Mullins PG, et al. Effects of ketamine on anterior cingulate glutamate metabolism in healthy humans: a 4-T proton MRS study. Am J Psychiatry 2005;162:394-6.
13. Tortorella A, Monteleone P, Fabrazzo M, et al. Plasma concentrations of amino acids in chronic schizophrenics treated with clozapine. Neuropsychobiology 2001;44:167-71.
14. Alfredsson G, Wiesel FA. Monoamine metabolites and amino acids in serum from schizophrenic patients before and during sulpiride treatment. Psychopharmacology (Berl) 1989;99:322-7.
15. Hawkins RA, Peterson DR, Vina JR. The complementary membranes forming the blood-brain barrier. IUBMB Life 2002;54:101-7.
16. Alfredsson G, Wiesel FA, Tylec A. Relationships between glutamate and monoamine metabolites in cerebrospinal fluid and serum in healthy volunteers. Biol Psychiatry 1988;23:689-97.
17. Alfredsson G, Wiesel FA, Lindberg M. Glutamate and glutamine in cerebrospinal fluid and serum from healthy volunteers-analytical aspects. J Chromatogr 1988;424:378-84.
18. McGale EH, Pye IF, Stonier C, et al. Studies of the inter-relationship between cerebrospinal fluid and plasma amino acid concentrations in normal individuals. J Neurochem 1977;29:291-7.
19. Goff DC, Hennen J, Lyoo IK, et al. Modulation of brain and serum glutamatergic concentrations following a switch from conventional neuroleptics to olanzapine. Biol Psychiatry 2002;51:493-7.
20. American Psychiatric Association. Diagnostic and statistical manual of mental disorders. 4th ed. Washington: the Association; 1994.
21. Gruetter R. Automatic, localized in vivi adjustment of all first- and second-order shim coils. Magn Reson Med 1993;29:804-11.
22. Thompson RB, Allen PS. Response of metabolites with coupled spins to the STEAM sequence. Magn Reson Med 2001;45:955-65.
23. Hanstock CC, Allen PS. Segmentation of brain from a PRESS localised single volume using double inversion recovery for simultaneous T1 nulling [poster]. International Society for Magnetic Resonance in Medicine; 2000 Apr 1-7; Denver.
24. Redpath TW, Smith FW. Technical note: use of a double inversion recovery pulse sequence to image selectively grey or white brain matter. Br J Radiol 1994;67:1258-63.
25. Hashimoto A, Nishikawa T, Oka T, et al. Determination of free amino acid enantiomers in rat brain and serum by high-performance liquid chromatography after derivatization with N-tertbutyloxycarbonyl-L-cysteine and o-phthaldialdehyde. J Chromatogr 1992;582:41-8.
26. Glaeser BS, Maher TJ, Wurtman RJ. Changes in brain levels of acidic, basic, and neutral amino acids after consumption of single meals containing various proportions of protein. J Neurochem 1983;41:1016-21.